Novel PROTAC to target FKBP12: the potential to enhance bone morphogenetic protein activity and apoptosis in multiple myeloma
Ingrid Quist-Løkken(Norwegian University of Science and Technology), Toril Holien(Norwegian University of Science and Technology)
Cited by 3
Related Papers
Activin A inhibits BMP-signaling by binding ACVR2A and ACVR2B
|Cell Communication and Signaling|2015|175
TGF-β contamination of purified recombinant GDF15
|PLoS ONE|2017|89
GREM1 is associated with metastasis and predicts poor prognosis in ER-negative breast cancer patients
|Cell Communication and Signaling|2019|56